Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?
Publication date
2025
Authors
Achten, Anouk
Muller, Steven A
Zwetsloot, Peter Paul
Michels, Michelle
van der Meer, Peter
Nienhuis, Hans L A
van der Meer, Manon G
van Empel, Vanessa P M
Oerlemans, Marish
Knackstedt, Christian
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
ATTR, amyloid, amyloidosis, cardiomyopathy, genetic, Taverne, Internal Medicine, Cardiology and Cardiovascular Medicine
Citation
Achten, A, Muller, S A, Zwetsloot, P-P, Michels, M, van der Meer, P, Nienhuis, H L A, van der Meer, M G, van Empel, V P M, Oerlemans, M I F J & Knackstedt, C 2025, 'Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?', Expert Review of Cardiovascular Therapy, vol. 23, no. 1-2, pp. 1-4. https://doi.org/10.1080/14779072.2025.2463333